<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News, Articles, and Medical Journals&#187; Heart</title>
	<atom:link href="http://d02now.com/category/internal/heart/feed" rel="self" type="application/rss+xml" />
	<link>http://d02now.com</link>
	<description>download your medical article, health news, and free medical journal</description>
	<lastBuildDate>Tue, 09 Mar 2010 03:18:01 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Statins in Combinations with Fibrates Reported to Cause Rhabdomyolysis</title>
		<link>http://d02now.com/internal/statins-in-combinations-with-fibrates-reported-to-cause-rhabdomyolysis.html</link>
		<comments>http://d02now.com/internal/statins-in-combinations-with-fibrates-reported-to-cause-rhabdomyolysis.html#comments</comments>
		<pubDate>Sun, 19 Apr 2009 18:29:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[Fibrate]]></category>
		<category><![CDATA[Hyperlipidemia]]></category>
		<category><![CDATA[Severe Myopathy]]></category>
		<category><![CDATA[Statin]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/04/20/statins-in-combinations-with-fibrates-reported-to-cause-rhabdomyolysis/</guid>
		<description><![CDATA[Anything that destroys muscle tissue can cause rhabdomyolysis. The causes of rhabdomyolysis can be classified as  either physical or non-physical. Non-physical causes reported to cause rhabdomyolysis include: medications of statins, especially when prescribed in combinations with fibrates. 
The following article will describe reportation of severe myopathy case and rhabdomyolysis associated with cerivastatin-gemfibrozil combination therapy. [...]]]></description>
		<wfw:commentRss>http://d02now.com/internal/statins-in-combinations-with-fibrates-reported-to-cause-rhabdomyolysis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mercury Poisoning in Fatty Acid and Its Association to Cardiovascular Event</title>
		<link>http://d02now.com/internal/heart/mercury-poisoning-in-fatty-acid-and-its-association-to-cardiovascular-event.html</link>
		<comments>http://d02now.com/internal/heart/mercury-poisoning-in-fatty-acid-and-its-association-to-cardiovascular-event.html#comments</comments>
		<pubDate>Sat, 18 Apr 2009 02:07:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Mycordial Infarct]]></category>
		<category><![CDATA[AMI]]></category>
		<category><![CDATA[Mercury Exposure]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/04/18/mercury-poisoning-in-fatty-acid-and-its-association-to-cardiovascular-event/</guid>
		<description><![CDATA[Mercury is the only metal liquid at standard conditions for temperature and pressure, with a melting point of &#8722;38.83&#176;C.  Its boiling point of 356.73&#176;C gives it one of the narrowest liquid ranges of any metal. It is highly toxic by ingestion or inhalation of the dust, and mercury poisoning can also result from exposure [...]]]></description>
		<wfw:commentRss>http://d02now.com/internal/heart/mercury-poisoning-in-fatty-acid-and-its-association-to-cardiovascular-event.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does Statin Regiment (Rosuvastatin) associated with reducing high CRP Levels?</title>
		<link>http://d02now.com/internal/does-statin-regiment-rosuvastatin-associated-with-reducing-high-crp-levels.html</link>
		<comments>http://d02now.com/internal/does-statin-regiment-rosuvastatin-associated-with-reducing-high-crp-levels.html#comments</comments>
		<pubDate>Wed, 08 Apr 2009 06:16:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[JUPITER]]></category>
		<category><![CDATA[Statin]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/04/08/does-statin-regiment-rosuvastatin-associated-with-reducing-high-crp-levels/</guid>
		<description><![CDATA[currently the treatment of myocardial infarction, stroke, and death from cardiovascular causes recommend statin therapy for patients with established vascular disease, diabetes, and hyperlipidemia. Many previous study shown that statin therapy reduces high-sensitivity C-reactive protein levels.]]></description>
		<wfw:commentRss>http://d02now.com/internal/does-statin-regiment-rosuvastatin-associated-with-reducing-high-crp-levels.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does Digoxin Really Have a Role in The Treatment of Heart Failure?</title>
		<link>http://d02now.com/internal/does-digoxin-really-have-a-role-in-the-treatment-of-heart-failure.html</link>
		<comments>http://d02now.com/internal/does-digoxin-really-have-a-role-in-the-treatment-of-heart-failure.html#comments</comments>
		<pubDate>Wed, 01 Apr 2009 19:22:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Coronary Artery Disease]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[Digoxin Level]]></category>
		<category><![CDATA[Digoxin Role]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/04/02/does-digoxin-really-have-a-role-in-the-treatment-of-heart-failure/</guid>
		<description><![CDATA[Digoxin has only been shown to effectively control heart rate at rest and, therefore, should only be used as a second-line therapy for heart rate control in patients with atrial fibrillation.]]></description>
		<wfw:commentRss>http://d02now.com/internal/does-digoxin-really-have-a-role-in-the-treatment-of-heart-failure.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Digoxin&#8217;s Efficacy for Women in the Treatment of Heart Failure</title>
		<link>http://d02now.com/internal/digoxins-efficacy-for-women-in-the-treatment-of-heart-failure.html</link>
		<comments>http://d02now.com/internal/digoxins-efficacy-for-women-in-the-treatment-of-heart-failure.html#comments</comments>
		<pubDate>Wed, 01 Apr 2009 17:48:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[DIG]]></category>
		<category><![CDATA[Digoxin Level]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/04/02/digoxins-efficacy-for-women-in-the-treatment-of-heart-failure/</guid>
		<description><![CDATA[The Digitalis Investigation Group trial did not report sex-specific subgroup analyses, and current clinical guidelines do not differentiate between the use of digoxin in men and the use of this agent in women. Accordingly, researchers investigated whether the effect of digoxin therapy varied according to the sex of the patients in the Digitalis Investigation Group trial.]]></description>
		<wfw:commentRss>http://d02now.com/internal/digoxins-efficacy-for-women-in-the-treatment-of-heart-failure.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Effect of Digoxin Serum Level on The Survival of Patients with Heart Failure</title>
		<link>http://d02now.com/internal/the-effect-of-digoxin-serum-level-on-the-survival-of-patients-with-heart-failure.html</link>
		<comments>http://d02now.com/internal/the-effect-of-digoxin-serum-level-on-the-survival-of-patients-with-heart-failure.html#comments</comments>
		<pubDate>Fri, 27 Mar 2009 17:51:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[Digoxin]]></category>
		<category><![CDATA[Heart Failure]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/28/the-effect-of-digoxin-serum-level-on-the-survival-of-patients-with-heart-failure/</guid>
		<description><![CDATA[After the publication of the Digitalis Investigation Group (DIG) stated that digoxin therapy had no effect on mortality  but modestly reduced hospitalizations due to worsening heart failure, concerns have been raised regarding the relative efficacy of Serum Digoxin Concentration (SDC). Many previous study described Higher SDCs (greater than 1.0 ng/mL)have been associated with improved [...]]]></description>
		<wfw:commentRss>http://d02now.com/internal/the-effect-of-digoxin-serum-level-on-the-survival-of-patients-with-heart-failure.html/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Updated Guidelines Focused on Suspected Pulmonary Embolism</title>
		<link>http://d02now.com/internal/updated-guidelines-focused-on-suspected-pulmonary-embolism.html</link>
		<comments>http://d02now.com/internal/updated-guidelines-focused-on-suspected-pulmonary-embolism.html#comments</comments>
		<pubDate>Fri, 27 Mar 2009 02:36:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Pulmonology]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[Pulmonary Embolism]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/27/updated-guidelines-focused-on-suspected-pulmonary-embolism/</guid>
		<description><![CDATA[I found a structured guideline, comprising a reference section, summary of recommendations, and a practical  section for junior doctors about the management of suspected acute pulmonary embolism.]]></description>
		<wfw:commentRss>http://d02now.com/internal/updated-guidelines-focused-on-suspected-pulmonary-embolism.html/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Cardiac Tn I Induces Severe Autoimmune Inflammation in the Myocardium</title>
		<link>http://d02now.com/internal/heart/cardiac-tn-i-induces-severe-autoimmune-inflammation-in-the-myocardium.html</link>
		<comments>http://d02now.com/internal/heart/cardiac-tn-i-induces-severe-autoimmune-inflammation-in-the-myocardium.html#comments</comments>
		<pubDate>Wed, 25 Mar 2009 08:27:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Coronary Artery Disease]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Mycordial Infarct]]></category>
		<category><![CDATA[Troponin]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/25/cardiac-tn-i-induces-severe-autoimmune-inflammation-in-the-myocardium/</guid>
		<description><![CDATA[Ziya Kaya, MD and colleagues from Department of Internal Medicine III, Cardiology, University of Heidelberg, Germany took animal model experiment to study the effects on production of troponin-specific autoantibodies, cross-reactivity of autoantibodies, troponin-specific cellular response, inflammation, and expression of inflammatory cytokines, chemokines, fibrosis, heart function, ischemia/reperfusion injury, myocardial remodeling, and survival of the animals]]></description>
		<wfw:commentRss>http://d02now.com/internal/heart/cardiac-tn-i-induces-severe-autoimmune-inflammation-in-the-myocardium.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chronic Kidney Disease and Ischemic Stroke in Relation with Atrial Fibrillation</title>
		<link>http://d02now.com/internal/heart/chronic-kidney-disease-and-ischemic-stroke-in-relation-with-atrial-fibrillation.html</link>
		<comments>http://d02now.com/internal/heart/chronic-kidney-disease-and-ischemic-stroke-in-relation-with-atrial-fibrillation.html#comments</comments>
		<pubDate>Sun, 22 Mar 2009 17:30:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Atrial Fibrillation]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[Heart Journal]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/23/chronic-kidney-disease-and-ischemic-stroke-in-relation-with-atrial-fibrillation/</guid>
		<description><![CDATA[Chronic kidney disease (CKD), defined as reduced glomerular filtration rate (GFR) and/or proteinuria, markedly increases the risk for cardiovascular events in the general population. Chronic kidney disease is a major cardiovascular risk factor, but whether it independently increases the risk for ischemic stroke in persons with AF is unknown, according to the article.]]></description>
		<wfw:commentRss>http://d02now.com/internal/heart/chronic-kidney-disease-and-ischemic-stroke-in-relation-with-atrial-fibrillation.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>All About Patent Ductus Arteriosus</title>
		<link>http://d02now.com/internal/all-about-patent-ductus-arteriosus.html</link>
		<comments>http://d02now.com/internal/all-about-patent-ductus-arteriosus.html#comments</comments>
		<pubDate>Sun, 22 Mar 2009 10:34:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Heart]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[PDA]]></category>
		<category><![CDATA[Congenital Heart Disease]]></category>
		<category><![CDATA[Journal of Cardiology]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/22/all-about-patent-ductus-arteriosus/</guid>
		<description><![CDATA[Patent Ductus Arteriosus (PDA) is a congenital heart defect wherein a child&#8217;s ductus arteriosus fails to close after  birth. Symptoms are uncommon but in the first year of life include increased work of breathing and poor weight gain. In older children or adults the PDA may lead to congestive heart failure if left uncorrected [...]]]></description>
		<wfw:commentRss>http://d02now.com/internal/all-about-patent-ductus-arteriosus.html/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
